(lp0
S'BioDelivery Sciences International and Rexahn Pharmaceuticals See Share Values ... Yahoo Finance - 18 hours ago BioDelivery Sciences International went up 8.57% to close at $1.90 on Monday. The stock traded between $1.90 and $1.76 on volume of 409,980 shares traded.BioDelivery Sciences International, Inc.  Given a $5.00 Price Target at ... - Chaffey BreezeLatest Stocks: The Cantor Fitzgerald Analysts Give BioDelivery Sciences ... - Petro Global News 24'
p1
aS"Today's Brokerage Rating: BioDelivery Sciences International, Inc. (BDSI ... StockNewsJournal - Mar 27, 2017 ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.Sales Growth Analysis: BioDelivery Sciences International, Inc. (BDSI ... - USA Commerce Daily"
p2
aS'BioDelivery Sciences to Host Conference Call and Webcast Reporting Fourth ... PR Newswire  - Mar 9, 2017 RALEIGH, N.C., March 9, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc.  announced that it will report its fourth quarter and full-year 2016 financial results and host a conference call and webcast at 8:00 AM Eastern Time on&nbsp;...FY2017 EPS Estimates for BioDelivery Sciences International, Inc. (BDSI ... - Sports PerspectivesBioDelivery Sciences International Inc. - Receive News &amp; Ratings Daily - BBNS'
p3
aS'BioDelivery Sciences Announces the Hiring of Peter Ginsberg as Vice President ... PR Newswire  - Dec 14, 2016 RALEIGH, N.C., Dec. 14, 2016 /PRNewswire/ -- BioDelivery Sciences International, Inc.  announced that Peter Ginsberg has joined the company as Vice President of Business Development.Company Update : Why BioDelivery Sciences International, Inc ... - Smarter AnalystOn heels of Belbuca reacquisition, BDSI makes business development hire - Triangle Business Journal'
p4
aS'BioDelivery Sciences Reacquires License to BELBUCA from Endo Pharmaceuticals PR Newswire  - Dec 8, 2016 RALEIGH, N.C., Dec. 8, 2016 /PRNewswire/ --BioDelivery Sciences International, Inc.  announced that it has entered into an agreement with Endo Pharmaceuticals, Inc.  terminating their licensing of rights for BELBUCA&nbsp;...BioDelivery Regains Belbuca Opioid Rights  - InvestopediaEndo Sells Back Rights for Opioid Painkiller - Wall Street Journal'
p5
aS'BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and ... PR Newswire  - Mar 17, 2017 RALEIGH, N.C., March 17, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc.  today reported financial results for the fourth quarter and full year ended December 31, 2016, and provided an update on recent business highlights and&nbsp;...'
p6
aS'MonoSol Rx Files Patent Infringement Suit against BioDelivery Sciences ... GlobeNewswire  - Jan 13, 2017 ... a specialty pharmaceutical company utilizing its PharmFilm drug delivery technology to improve patient outcomes and to address unmet needs, today filed a patent infringement case against BioDelivery Sciences International, Inc. (Nasdaq:BDSI ...'
p7
aS"Can BioDelivery Succeed With Belbuca? Seeking Alpha - Feb 10, 2017 BioDelivery  gave a pretty good presentation about Belbuca and the company's sales and marketing strategy going forward."
p8
aS'BioDelivery Sciences International, Inc.  Shares Open Higher on Back of ... Smarter Analyst - Sep 23, 2016 BioDelivery Sciences International, Inc.  shares are up 13% this morning, after Janney Montgomery analyst Ken Trbovich upgraded BDSI from a Neutral to a Buy rating with a price target of $4, which implies an upside of 63% from current&nbsp;...Janney Montgomery Scott Upgrades BioDelivery Sciences International  to Buy - StreetInsider.com'
p9
aS'BioDelivery Sciences to Hold Analyst and Investor Day to Discuss BELBUCA ... PR Newswire  - Jan 26, 2017 RALEIGH, N.C., Jan. 26, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc.  will host an event for analysts and investors from 12:00 PM - 2:30 PM Eastern Time on Wednesday, February 1st, 2017, in New York City, to discuss&nbsp;...'
p10
a.